Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 20659094)

Published in Am J Transplant on August 01, 2010

Authors

D Collett1, L Mumford, N R Banner, J Neuberger, C Watson

Author Affiliations

1: Statistics and Clinical Audit, NHS Blood and Transplant, Bristol BS34 8RR, UK. dave.collett@nhsbt.nhs.uk

Articles citing this

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med (2012) 1.62

Cumulative incidence of cancer after solid organ transplantation. Cancer (2013) 1.58

Liver transplantation in alcoholic liver disease current status and controversies. World J Gastroenterol (2013) 1.30

Cancer in the transplant recipient. Cold Spring Harb Perspect Med (2013) 1.06

HPV-related cancers after solid organ transplantation in the United States. Am J Transplant (2013) 1.03

Colorectal cancer and immunity: what we know and perspectives. World J Gastroenterol (2014) 1.00

Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant (2013) 0.98

Systematic review of melanoma incidence and prognosis in solid organ transplant recipients. Transplant Res (2014) 0.96

Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94

Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant (2013) 0.92

De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant (2013) 0.91

Risk of bladder cancer in renal transplant recipients: a meta-analysis. Br J Cancer (2014) 0.90

Cancer Metastases: Early Dissemination and Late Recurrences. Cancer Growth Metastasis (2015) 0.86

Donor transmitted and de novo cancer after liver transplantation. World J Gastroenterol (2014) 0.85

Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol (2013) 0.81

Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients. Am J Transplant (2014) 0.80

Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant (2016) 0.79

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78

Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One (2016) 0.78

Malignancies after pediatric kidney transplantation: more than PTLD? Pediatr Nephrol (2013) 0.78

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues. World J Gastroenterol (2015) 0.77

Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis. BMC Cancer (2014) 0.77

Malignancies after living-donor and cadaveric lung transplantations in Japanese patients. Surg Today (2016) 0.77

Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men. PLoS One (2013) 0.77

Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis. World J Hepatol (2015) 0.76

Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan. PLoS One (2016) 0.75

Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management. World J Gastroenterol (2016) 0.75

Frequency and spectrum of metachronous malignancies in heart transplant recipients: a 11-year-experience at a German heart center. Int J Clin Exp Pathol (2013) 0.75

Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience. Eurasian J Med (2016) 0.75

Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control. PLoS One (2016) 0.75

Cancer-related outcomes in kidney allograft recipients in England versus New York State: a comparative population-cohort analysis between 2003 and 2013. Cancer Med (2017) 0.75

Chemotherapy for urothelial carcinoma in renal transplantation patients: Initial results from a single center. Mol Clin Oncol (2015) 0.75

Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies. Mol Clin Oncol (2016) 0.75

The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model. Transplant Direct (2016) 0.75

De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study. Oncotarget (2016) 0.75

Viruses in case series of tumors: Consistent presence in different cancers in the same subject. PLoS One (2017) 0.75

Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States. Am J Transplant (2016) 0.75

Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy. World J Urol (2016) 0.75

Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation (2017) 0.75

The correlation between renal transplantation and liver carcinoma: a meta-analysis. Oncotarget (2017) 0.75

Articles by these authors

(truncated to the top 100)

Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res (1991) 6.59

Elective ventilation of potential organ donors. BMJ (1995) 5.50

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol (2000) 4.75

Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol (1989) 4.20

Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science (1995) 3.37

The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. J Epidemiol Community Health (1988) 3.35

Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut (1999) 3.10

Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09

The NHS as a theological institution. The ideal remains strong, but the practice too has to measure up. BMJ (2000) 2.81

Offering choice of treatment to patients with cancers. A review based on a symposium held at the 10th annual conference of The British Psychosocial Oncology Group, December 1993. Eur J Cancer (1995) 2.66

Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods (1985) 2.52

Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41

Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36

Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32

Surgical outcome in patients with epilepsy and dual pathology. Brain (1999) 2.19

MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology (1993) 2.04

Phytoremediation of heavy metal-contaminated land by trees--a review. Environ Int (2003) 2.01

Pancreas transplantation from donors after circulatory death from the United Kingdom. Am J Transplant (2012) 2.00

Regulation of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4 gene. Immunity (2001) 1.97

Computerised protocols for laboratory investigation and their effect on use of medical time and resources. J Clin Pathol (1992) 1.87

Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86

Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant (1990) 1.84

Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM (1996) 1.81

Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes. J Clin Endocrinol Metab (2005) 1.76

Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68

Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64

Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg (1993) 1.60

Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos (2000) 1.56

Halothane hepatitis: a model of immune mediated drug hepatotoxicity. Clin Sci (Lond) (1987) 1.54

Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet (1994) 1.53

Is ictal recording mandatory in temporal lobe epilepsy? Not when the interictal electroencephalogram and hippocampal atrophy coincide. Arch Neurol (2000) 1.52

Recombinant plasmids containing Xenopus laevis globin structural genes derived from complementary DNA. Nucleic Acids Res (1978) 1.52

Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc (2000) 1.52

Role of users of health care in achieving a quality service. Qual Health Care (1994) 1.49

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion (2000) 1.48

Glove usage and reporting of needlestick injuries by junior hospital medical staff. Ann R Coll Surg Engl (1998) 1.47

The histamine-synthesizing enzyme histidine decarboxylase is upregulated by keratinocytes in atopic skin. Br J Dermatol (2014) 1.42

An updated protocol for abortion surveillance with ultrasound and immediate pathology. Obstet Gynecol (1994) 1.41

Selective omission of the donor cross-match before renal transplantation: efficacy, safety and effects on cold storage time. Transplantation (2000) 1.40

Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant (2009) 1.39

Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study. Eur Respir J (2005) 1.38

Ageing Britain--challenges and opportunities for general practice. Br J Gen Pract (2001) 1.38

Liver transplantation for alcoholic cirrhosis: current situation. Hosp Med (1998) 1.38

Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet (1980) 1.37

End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36

Volumetric MRI, pathological, and neuropsychological progression in hippocampal sclerosis. Neurology (2001) 1.32

Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut (1981) 1.27

Halothane anaesthesia and liver damage. Br Med J (Clin Res Ed) (1984) 1.24

Long-term use of cyclosporin in liver grafting. Q J Med (1985) 1.24

C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am J Transplant (2007) 1.24

Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation (1986) 1.24

Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl (2001) 1.24

De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant (2011) 1.22

Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology (1999) 1.20

Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation (2004) 1.20

Familial persistent ductus arteriosus. Arch Dis Child (1986) 1.19

Fulminant hepatic failure caused by tuberculosis. Gut (1995) 1.18

Oral contraceptives and hepatocellular carcinoma. Br Med J (Clin Res Ed) (1986) 1.18

Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant (2004) 1.17

Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res (1990) 1.16

Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med (2005) 1.16

Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol (1988) 1.16

Patterns of alcohol consumption after liver transplantation. Gut (1998) 1.15

Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology (1995) 1.14

Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation (2000) 1.13

Hepatic damage after exposure to halothane in medical personnel. Br J Anaesth (1981) 1.13

Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography? Ann Neurol (2000) 1.12

Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology (2001) 1.09

Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache (2001) 1.09

Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. Neuroscience (2008) 1.08

Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J Med Genet (2003) 1.07

Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology (2000) 1.07

Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci. Comput Aided Surg (1998) 1.04

Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet (1992) 1.03

Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology (1993) 1.03

Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology (2001) 1.02

Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation (2000) 1.02

Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study. Health Technol Assess (2013) 1.02

A note on the adrenal gland in the rat. J Physiol (1907) 1.01

Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. Am J Transplant (2008) 1.00

Improvement in hypertrophic hepatic osteoarthropathy after liver transplantation. Lancet (1988) 1.00

Primary lung carcinoma after heart or lung transplantation: management and outcome. J Thorac Cardiovasc Surg (2002) 1.00

In vitro studies on the mechanism of increased serum IgM levels in primary biliary cirrhosis. Clin Exp Immunol (1985) 1.00

Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology (2000) 0.99

Periventricular nodular heterotopia and intractable temporal lobe epilepsy: poor outcome after temporal lobe resection. Ann Neurol (1997) 0.99

Lead mineral transformation by fungi. Curr Biol (1999) 0.98

Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut (1985) 0.98

Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation (1991) 0.98

Sulfated glycoproteins secreted by human vascular endothelial cells. J Biol Chem (1982) 0.98

Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology (1984) 0.98

Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease. Gut (1984) 0.97

Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation (1984) 0.97

Use of constitutive G protein-coupled receptor activity for drug discovery. Mol Pharmacol (2000) 0.97

High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion (2001) 0.97

Long term transtracheal oxygen delivery through microcatheter in patients with hypoxaemia due to chronic obstructive airways disease. Br Med J (Clin Res Ed) (1986) 0.97

Location, localization and surgical treatment of cardiac pheochromocytoma. Am J Cardiol (1992) 0.96

Autoimmune overlap syndromes. Hepatology (2001) 0.96

A breakthrough in gun control in Australia after the Port Arthur massacre. Inj Prev (1996) 0.95

Visual field loss in migraine. Ophthalmology (1989) 0.95